| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:Satavaptan;Satavaptan
CAS:185913-78-4
Purity:98% Package:5 mg
|
|
| | satavaptan Basic information |
| Product Name: | satavaptan | | Synonyms: | satavaptan;SR 121463;N-tert-butyl-4-[5'-ethoxy-4-(2-morpholin-4-ylethoxy)-2'-oxospiro[cyclohexane-1,3'-indole]-1'-yl]sulfonyl-3-methoxybenzamide;Benzamide, N-(1,1-dimethylethyl)-4-[[cis-5'-ethoxy-4-[2-(4-morpholinyl)ethoxy]-2'-oxospiro[cyclohexane-1,3'-[3H]indol]-1'(2'H)-yl]sulfonyl]-3-methoxy- | | CAS: | 185913-78-4 | | MF: | C33H45N3O8S | | MW: | 643.79 | | EINECS: | | | Product Categories: | | | Mol File: | 185913-78-4.mol |  |
| | satavaptan Chemical Properties |
| density | 1.31±0.1 g/cm3(Predicted) | | pka | 14.04±0.46(Predicted) |
| | satavaptan Usage And Synthesis |
| Definition | ChEBI: Satavaptan is a vasopressin V2 receptor antagonist that has been shown to improve hyponatremia in patients with cirrhosis, congestive heart failure, and syndrome of inappropriate antidiuresis. It has a role as a vasopressin receptor antagonist and an aquaretic. It is a member of morpholines, an aromatic ether, a member of benzamides, a secondary carboxamide, a monomethoxybenzene, a sulfonamide and an oxaspiro compound. |
| | satavaptan Preparation Products And Raw materials |
|